SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-20-000083
Filing Date
2020-08-10
Accepted
2020-08-10 07:32:05
Documents
9
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesnform8-k2q2020pr.htm 8-K 31062
2 EXHIBIT 99.1 ex991sesn2q2020pressrele.htm EX-99.1 23790
3 ex991sesn2q2020pressrele001.jpg GRAPHIC 245780
4 ex991sesn2q2020pressrele002.jpg GRAPHIC 266075
5 ex991sesn2q2020pressrele003.jpg GRAPHIC 287944
6 ex991sesn2q2020pressrele004.jpg GRAPHIC 300814
7 ex991sesn2q2020pressrele005.jpg GRAPHIC 49630
8 ex991sesn2q2020pressrele006.jpg GRAPHIC 75618
9 ex991sesn2q2020pressrele007.jpg GRAPHIC 95135
  Complete submission text file 0001485003-20-000083.txt   1876184
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 201087096
SIC: 2834 Pharmaceutical Preparations